Recombinant Human IGFBP5
An IGF-binding protein, IBP-5 is produced by fibroblasts, myoblasts, osteoblasts and vascular smooth muscle cells. IBP-5 has been shown to specifically inhibit breast cancer cell growth by inducing apoptosis. IBP-5 contains an IGFBP domain and a thyroglobulin type-1 domain.
Product Specifications
CAS Number
9000-83-3
Gene Name
IGFBP5
Gene Aliases
IBP-5, IGF-binding protein 5, IGFBP-5, IGF-BP5<br/>Recombinant Human Insulin-Like Growth Factor Binding Protein 5 (IGFBP5)
Gene ID
3488
Accession Number
P24593
Organism
Human
Source
E. coli
Concentration
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Purity
>95% as determined by SDS-PAGE
Solubility
A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Function
N.A.
Molecular Weight
26.5
Shipping Conditions
Ambient Temperature
Storage Conditions
The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity.
Avoid repeated freeze/thaw cycles.
Appearance
Lyophilized Powder
Formulation
Lyophilized from a 0.2 μm filtered solution of 10mM sodium Citrate pH 3.0
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
